Page last updated: 2024-10-22

amitriptyline and Protein Aggregation, Pathological

amitriptyline has been researched along with Protein Aggregation, Pathological in 1 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Protein Aggregation, Pathological: A biochemical phenomenon in which misfolded proteins aggregate either intra- or extracellularly. Triggered by factors such as MUTATION; POST-TRANSLATIONAL MODIFICATIONS, and environmental stress, it is generally associated with ALZHEIMER DISEASE; PARKINSON DISEASE; HUNTINGTON DISEASE; and TYPE 2 DIABETES MELLITUS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Niziolek, GM1
Hoehn, RS1
Seitz, AP1
Jernigan, PL1
Makley, AT1
Gulbins, E1
Edwards, MJ1
Goodman, MD1

Other Studies

1 other study available for amitriptyline and Protein Aggregation, Pathological

ArticleYear
The Role of Acid Sphingomyelinase Inhibition in Repetitive Mild Traumatic Brain Injury.
    The Journal of surgical research, 2021, Volume: 259

    Topics: Amitriptyline; Animals; Brain Concussion; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Pr

2021